Co-Diagnostics, Inc. Net Income
Co-Diagnostics, Inc. (CODX) reported Net Income of -$6.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-13
- Co-Diagnostics, Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$6.28M.
- Co-Diagnostics, Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$9.14M.
- Co-Diagnostics, Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$25.85M.
- Co-Diagnostics, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$5.89M.
- Co-Diagnostics, Inc. net income (loss) attributable to parent for fiscal 2023 was -$35.33M.
- Co-Diagnostics, Inc. net income (loss) attributable to parent for fiscal 2022 was -$14.24M, a 138.84% decline from fiscal 2021.
- Co-Diagnostics, Inc. net income (loss) attributable to parent for fiscal 2021 was $36.66M, a 13.70% decline from fiscal 2020.
- Co-Diagnostics, Inc. net income (loss) attributable to parent for fiscal 2020 was $42.48M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.28M 10-Q · filed 2026-08-13 | -$15.42M 10-Q · filed 2026-08-13 | -$41.27M derived: sum of 3 quarters · filed 2026-08-13 | -$47.16M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$9.14M 10-Q · filed 2026-08-13 | -$34.99M derived: sum of 2 quarters · filed 2026-08-13 | -$40.88M derived: sum of 3 quarters · filed 2026-08-13 | -$48.61M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$25.85M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-07-21 | -$31.74M derived: sum of 2 quarters · filed 2026-07-21 | -$39.47M derived: sum of 3 quarters · filed 2026-08-13 | -$47.00M DEF 14A · filed 2026-07-21 | -$46.90M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$5.89M 10-Q · filed 2025-11-13 | -$13.62M derived: sum of 2 quarters · filed 2026-08-13 | -$21.15M 10-Q · filed 2025-11-13 | -$32.54M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$7.73M 10-Q · filed 2026-08-13 | -$15.26M 10-Q · filed 2026-08-13 | -$26.66M derived: sum of 3 quarters · filed 2026-08-13 | -$36.35M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$7.53M 10-Q · filed 2026-08-13 | -$18.93M derived: sum of 2 quarters · filed 2026-08-13 | -$28.62M derived: sum of 3 quarters · filed 2026-08-13 | -$36.22M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2024-12-31 | -$11.39M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-07-21 | -$21.09M derived: sum of 2 quarters · filed 2026-07-21 | -$28.69M derived: sum of 3 quarters · filed 2026-07-21 | -$38.00M DEF 14A · filed 2026-07-21 | -$37.64M 10-K · filed 2025-03-27 | ||
| 2024-09-30 | -$9.70M 10-Q · filed 2025-11-13 | -$17.30M derived: sum of 2 quarters · filed 2025-11-13 | -$26.61M 10-Q · filed 2025-11-13 | -$41.28M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$7.60M 10-Q · filed 2025-11-13 | -$16.91M 10-Q · filed 2025-08-14 | -$31.59M derived: sum of 3 quarters · filed 2025-11-13 | -$37.57M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-03-31 | -$9.31M 10-Q · filed 2025-11-13 | -$23.99M derived: sum of 2 quarters · filed 2025-11-13 | -$29.97M derived: sum of 3 quarters · filed 2025-11-13 | -$38.89M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2023-12-31 | -$14.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$20.66M derived: sum of 2 quarters · filed 2025-03-27 | -$29.58M derived: sum of 3 quarters · filed 2025-03-27 | -$35.33M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$5.98M 10-Q · filed 2024-11-07 | -$14.90M derived: sum of 2 quarters · filed 2024-11-07 | -$20.66M 10-Q · filed 2024-11-07 | -$42.56M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$8.92M 10-Q · filed 2024-11-07 | -$14.67M 10-Q · filed 2024-08-08 | -$36.58M derived: sum of 3 quarters · filed 2024-11-07 | -$37.94M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-03-31 | -$5.76M 10-Q · filed 2024-11-07 | -$27.66M derived: sum of 2 quarters · filed 2024-11-07 | -$29.02M derived: sum of 3 quarters · filed 2024-11-07 | -$31.71M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2022-12-31 | -$21.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$23.27M derived: sum of 2 quarters · filed 2024-03-14 | -$25.95M derived: sum of 3 quarters · filed 2024-03-14 | -$14.24M 10-K · filed 2024-03-14 | |||
| 2022-09-30 | -$1.36M 10-Q · filed 2023-11-09 | -$4.05M derived: sum of 2 quarters · filed 2023-11-09 | $7.67M 10-Q · filed 2023-11-09 | $15.17M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$2.69M 10-Q · filed 2023-11-09 | -$2.69M 10-Q · filed 2022-08-11 | $9.03M 10-Q · filed 2023-08-10 | $16.53M derived: sum of 3 quarters · filed 2023-11-09 | $28.00M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $11.71M 10-Q · filed 2023-11-09 | $19.21M derived: sum of 2 quarters · filed 2023-11-09 | $30.69M derived: sum of 3 quarters · filed 2023-11-09 | $40.47M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2021-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $18.97M derived: sum of 2 quarters · filed 2023-03-16 | $28.76M derived: sum of 3 quarters · filed 2023-03-16 | $36.66M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $11.48M 10-Q · filed 2022-11-10 | $21.26M derived: sum of 2 quarters · filed 2022-11-10 | $29.16M 10-Q · filed 2022-11-10 | $41.97M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $9.79M 10-Q · filed 2022-11-10 | $17.68M 10-Q · filed 2022-08-11 | $30.49M derived: sum of 3 quarters · filed 2022-11-10 | $46.22M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-03-31 | $7.90M 10-Q · filed 2022-11-10 | $20.71M derived: sum of 2 quarters · filed 2022-11-10 | $36.44M derived: sum of 3 quarters · filed 2022-11-10 | $51.44M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2020-12-31 | $12.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $28.54M derived: sum of 2 quarters · filed 2022-03-24 | $43.54M derived: sum of 3 quarters · filed 2022-03-24 | $42.48M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $15.73M 10-Q · filed 2021-11-12 | $30.74M derived: sum of 2 quarters · filed 2021-11-12 | $29.67M 10-Q · filed 2021-11-12 | $27.94M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $15.01M 10-Q · filed 2021-11-12 | $12.64M 10-Q · filed 2020-08-13 | $13.94M 10-Q · filed 2021-08-12 | $11.57M 10-Q · filed 2020-08-13 | $12.20M derived: sum of 3 quarters · filed 2021-11-12 | $10.46M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-03-31 | -$1.07M 10-Q · filed 2021-11-12 | -$2.80M derived: sum of 2 quarters · filed 2021-11-12 | -$4.55M derived: sum of 3 quarters · filed 2021-11-12 | -$5.89M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2019-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$3.48M derived: sum of 2 quarters · filed 2021-03-25 | -$4.83M derived: sum of 3 quarters · filed 2021-03-25 | -$6.20M 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$1.75M 10-Q · filed 2020-11-16 | -$3.09M derived: sum of 2 quarters · filed 2020-11-16 | -$4.46M 10-Q · filed 2020-11-16 | -$6.41M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | -$1.34M 10-Q · filed 2020-11-16 | -$2.71M 10-Q/A · filed 2020-11-03 | -$4.66M derived: sum of 3 quarters · filed 2020-11-16 | -$6.30M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-03-31 | -$1.37M 10-Q · filed 2020-11-16 | -$3.32M derived: sum of 2 quarters · filed 2020-11-16 | -$4.96M derived: sum of 3 quarters · filed 2020-11-16 | -$6.33M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2018-12-31 | -$1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$3.59M derived: sum of 2 quarters · filed 2020-03-30 | -$4.96M derived: sum of 3 quarters · filed 2020-03-30 | -$6.27M 10-K · filed 2020-03-30 | |||
| 2018-09-30 | -$1.64M 10-Q · filed 2019-11-12 | -$3.01M derived: sum of 2 quarters · filed 2019-11-12 | -$4.32M 10-Q · filed 2019-11-12 | -$5.83M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$1.37M 10-Q · filed 2019-11-12 | -$2.68M 10-Q · filed 2019-08-14 | -$4.19M derived: sum of 3 quarters · filed 2019-11-12 | -$8.08M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-03-31 | -$1.31M 10-Q · filed 2019-11-12 | -$2.82M derived: sum of 2 quarters · filed 2019-11-12 | -$6.71M derived: sum of 3 quarters · filed 2019-11-12 | -$7.56M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2017-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$5.40M derived: sum of 2 quarters · filed 2019-04-01 | -$6.25M derived: sum of 3 quarters · filed 2019-04-01 | -$6.96M 10-K · filed 2019-04-01 | |||
| 2017-09-30 | -$3.89M 10-Q · filed 2018-11-14 | -$4.75M derived: sum of 2 quarters · filed 2018-11-14 | -$5.45M 10-Q · filed 2018-11-14 | -$5.98M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | -$855.01K 10-Q · filed 2018-08-10 | -$1.56M 10-Q · filed 2018-08-10 | -$2.09M derived: sum of 3 quarters · filed 2018-08-10 | -$2.54M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2017-03-31 | -$705.74K 10-Q · filed 2018-05-14 | -$1.23M derived: sum of 2 quarters · filed 2018-05-14 | -$1.68M derived: sum of 3 quarters · filed 2018-05-14 | -$2.12M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$525.25K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$975.20K derived: sum of 2 quarters · filed 2018-03-28 | -$1.42M derived: sum of 3 quarters · filed 2018-03-28 | -$1.93M 10-K · filed 2018-03-28 | |||
| 2016-09-30 | -$449.95K 10-Q · filed 2017-11-14 | -$892.59K derived: sum of 2 quarters · filed 2017-11-14 | -$1.40M 10-Q · filed 2017-11-14 | ||||
| 2016-06-30 | -$442.64K 10-Q · filed 2017-08-25 | -$953.49K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |